))
Israeli Technology Founders Speak: Conversations with Successful Israeli Hitech and Biotech Entrepreneurs
«
»
Alon Ben-Noon of NeuroSense Therapeutics
Manage episode 337501904 series 3382134
Israeli Technology Founders Speak and JMB Davis Ben-David International IP Law Firm에서 제공하는 콘텐츠입니다. 에피소드, 그래픽, 팟캐스트 설명을 포함한 모든 팟캐스트 콘텐츠는 Israeli Technology Founders Speak and JMB Davis Ben-David International IP Law Firm 또는 해당 팟캐스트 플랫폼 파트너가 직접 업로드하고 제공합니다. 누군가가 귀하의 허락 없이 귀하의 저작물을 사용하고 있다고 생각되는 경우 여기에 설명된 절차를 따르실 수 있습니다 https://ko.player.fm/legal.
Alon Ben-Noon is the CEO and co-founder of NeuroSense Therapeutics, a clinical stage drug development company offering ground-breaking treatment for ALS patients, as well as other neurodegenerative diseases. Avraham Hermon sat down with Alon in the NeuroSense offices in Herzliya. They discussed the inspiration for creating a new ALS treatment, how to create results using a small team, raising money, dealing with investors, the mentality of a startup founder, the role of patents in biotech companies and much more. Do you have a great innovation? We'd love to hear from you. Contact us by going to jmbdavis.com/startup/contact. Learn more at jmbdavis.com and jmbdavis.com/startup. Also available at https://soundcloud.com/jmbdavis/jeff-gabbay-of-argaman-technologies. Listen to all of the episodes at https://jmbdavis.com/podcast.
…
continue reading
32 에피소드
공유
